HomeQuestion

Should CYP2C19 genotype testing be performed in patients presenting with ISR on Plavix?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Do you prefer the routine use of bivalirudin over UFH during PCI cases in patients presenting with ACS?

What advice would you give to patients with refractory nausea and vomiting at home who are unable to take oral medications but have recently had a PCI and stent placement requiring uninterrupted DAPT?

Do you favor ticagrelor or prasugrel first-line for the treatment of ACS with planned PCI, provided no contraindications to either agent?

Do you recommend SGLT2 inhibitors be held for 3-4 days prior to an elective diagnostic cardiac catheterization or coronary intervention if the patient is made NPO the day of the procedure?

What clinical features in suspected ANOCA push you toward proceeding directly to invasive coronary function testing rather than empirically escalating antianginal therapy first?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.